NO973341D0 - Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for vasodilatorisk behandling eller profylakse - Google Patents
Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for vasodilatorisk behandling eller profylakseInfo
- Publication number
- NO973341D0 NO973341D0 NO973341A NO973341A NO973341D0 NO 973341 D0 NO973341 D0 NO 973341D0 NO 973341 A NO973341 A NO 973341A NO 973341 A NO973341 A NO 973341A NO 973341 D0 NO973341 D0 NO 973341D0
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- diphenylchromanes
- prophylaxis
- vasodilatory
- pharmaceutical preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK6795 | 1995-01-20 | ||
| DK77595 | 1995-06-30 | ||
| PCT/DK1996/000013 WO1996022093A1 (en) | 1995-01-20 | 1996-01-10 | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for vasodilatory treatment or prophylaxis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO973341L NO973341L (no) | 1997-07-18 |
| NO973341D0 true NO973341D0 (no) | 1997-07-18 |
Family
ID=26063230
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO973341A NO973341D0 (no) | 1995-01-20 | 1997-07-18 | Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for vasodilatorisk behandling eller profylakse |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5886021A (no) |
| EP (1) | EP0804188A1 (no) |
| JP (1) | JPH10513154A (no) |
| KR (1) | KR19980701548A (no) |
| CN (1) | CN1168100A (no) |
| AU (1) | AU4329196A (no) |
| BR (1) | BR9606767A (no) |
| CA (1) | CA2208852A1 (no) |
| CZ (1) | CZ211897A3 (no) |
| HU (1) | HUP9800297A3 (no) |
| IL (1) | IL116827A (no) |
| NO (1) | NO973341D0 (no) |
| WO (1) | WO1996022093A1 (no) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8080675B2 (en) | 2004-09-21 | 2011-12-20 | Marshall Edwards, Inc. | Chroman derivatives, medicaments and use in therapy |
| US7601855B2 (en) | 2004-09-21 | 2009-10-13 | Novogen Research Pty Ltd | Substituted chroman derivatives, medicaments and use in therapy |
| CA2816319C (en) | 2010-11-01 | 2020-06-30 | Marshall Edwards, Inc. | Isoflavonoid compounds and methods for the treatment of cancer |
| MX368063B (es) | 2014-02-07 | 2019-09-18 | Novogen ltd | Compuestos de benzopirano funcionalizados y uso de los mismos. |
| ES2877712T3 (es) | 2015-02-02 | 2021-11-17 | Mei Pharma Inc | Terapias combinadas para su uso en el tratamiento del cáncer de mama |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3340276A (en) * | 1964-04-01 | 1967-09-05 | Ciba Geigy Corp | 3, 4-diphenyl-chromans |
| US3822287A (en) * | 1969-04-17 | 1974-07-02 | Rexall Drug Chemical | Process for preparation of substituted 3,4-(diphenyl)chromans |
| US4447622A (en) * | 1981-09-22 | 1984-05-08 | Council Of Scientific And Industrial Research Rafi Marg | Preparation of l- and d-isomers of dl-3,4-trans-2,2-disubstituted-3,4-diarylchromans and derivatives thereof |
| US5280040A (en) * | 1993-03-11 | 1994-01-18 | Zymogenetics, Inc. | Methods for reducing bone loss using centchroman derivatives |
-
1996
- 1996-01-10 CZ CZ972118A patent/CZ211897A3/cs unknown
- 1996-01-10 JP JP8521978A patent/JPH10513154A/ja active Pending
- 1996-01-10 HU HU9800297A patent/HUP9800297A3/hu unknown
- 1996-01-10 EP EP96900094A patent/EP0804188A1/en not_active Withdrawn
- 1996-01-10 BR BR9606767A patent/BR9606767A/pt unknown
- 1996-01-10 KR KR1019970704939A patent/KR19980701548A/ko not_active Application Discontinuation
- 1996-01-10 WO PCT/DK1996/000013 patent/WO1996022093A1/en not_active Application Discontinuation
- 1996-01-10 AU AU43291/96A patent/AU4329196A/en not_active Abandoned
- 1996-01-10 CA CA002208852A patent/CA2208852A1/en not_active Abandoned
- 1996-01-10 CN CN96191514A patent/CN1168100A/zh active Pending
- 1996-01-19 IL IL11682796A patent/IL116827A/xx active IP Right Grant
-
1997
- 1997-07-18 NO NO973341A patent/NO973341D0/no unknown
- 1997-08-18 US US08/912,802 patent/US5886021A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| HUP9800297A2 (hu) | 1998-12-28 |
| NO973341L (no) | 1997-07-18 |
| MX9705379A (es) | 1997-10-31 |
| CA2208852A1 (en) | 1996-07-25 |
| KR19980701548A (ko) | 1998-05-15 |
| JPH10513154A (ja) | 1998-12-15 |
| IL116827A (en) | 1999-11-30 |
| CN1168100A (zh) | 1997-12-17 |
| CZ211897A3 (en) | 1997-12-17 |
| AU4329196A (en) | 1996-08-07 |
| HUP9800297A3 (en) | 1999-12-28 |
| EP0804188A1 (en) | 1997-11-05 |
| BR9606767A (pt) | 1997-12-30 |
| IL116827A0 (en) | 1996-05-14 |
| US5886021A (en) | 1999-03-23 |
| WO1996022093A1 (en) | 1996-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO961006D0 (no) | Fosfonomononukleinsyrer, fremgangsmåter for fremstilling derav og anvendelse av forbindelsene | |
| NO973243D0 (no) | Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av gynekologiske sykdommer | |
| NO943888D0 (no) | Farmasöytisk preparat | |
| NL300258I2 (nl) | Farmaceutische samenstelling voor toepassing in debehandeling van. | |
| EE9700145A (et) | Tsükloalkaanpüridiinid, nende valmistamismeetod, kasutamine ravimite tootmiseks ja nimetatud ühendeid sisaldavad ravimid | |
| NO910828D0 (no) | Preparat for behandling av erektil funksjonssvikt. | |
| FI973828A0 (fi) | Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi | |
| EE9700031A (et) | Pürido-liitunud tienüül- ja furanüüloksasolidinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid | |
| EE03774B1 (et) | 5-O-desosaminüül-6-O-metüülerütronoliid A derivaadid, nende valmistamismeetod ja kasutamine bioaktiivsete produktide valmistamiseks | |
| NO961742D0 (no) | Anvendelse av retinoider i et kosmetisk preparat eller for fremstilling av et farmsöytisk preparat | |
| NO981008D0 (no) | Farmasöytisk formulering | |
| EE9600172A (et) | Puriin-6-ooni derivaadid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja ravimid | |
| EE9600018A (et) | 2,9-diasendatud puriin-6-oonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid | |
| EE04681B1 (et) | 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon | |
| EE03878B1 (et) | 5-O-desosaminüül-6-O-metüülerütronoliid A derivaadid, nende valmistamismeetod ja kasutamine bioaktiivsete ühendite valmistamiseks | |
| NO942303D0 (no) | Farmasöytisk preparat, samt fremgangsmåte for fremstilling derav | |
| NO973342D0 (no) | Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av cerebrale degenerative sykdommer | |
| FI961378A0 (fi) | Menetelmä N-metyyli-3-(1-metyyli-4-piperidinyyli)-14-indoli-5-etaanisulfonamidin valmistamiseksi | |
| NO973340D0 (no) | Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av fedme | |
| NO973341D0 (no) | Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for vasodilatorisk behandling eller profylakse | |
| NO960529D0 (no) | Substituerte benzensulfonylureaer og -tioureaer, fremgangsmåte for fremstilling av disse, og deres anvendelse for fremstilling av farmasöytiske preparater samt farmasöytiske preparater inneholdende forbindelsene | |
| ITFI950044A0 (it) | Composti biciclici, loro preparazione ed uso in composizioni farmaceutiche | |
| NO913162D0 (no) | Farmasoeytisk preparat for behandling av tonsillitt. | |
| NO973242D0 (no) | Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av idiopatisk eller fysiologisk gynekomasti | |
| FI974002A (fi) | Menetelmä ranitidiinihydrokloridi 1 muodon valmistamiseksi |